Limbal Stem Cell Deficiency after Topical Mitomycin C Therapy for Primary Acquired Melanosis with Atypia

Ophthalmology

Volumn 117, Issue 3, 2010, Pages 431-437

  Lichtinger, Alejandro ^a   Pe'er, Jacob ^a   Frucht Pery, Joseph ^a   Solomon, Abraham ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; FLUOROMETHOLONE; MITOMYCIN C;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA; CONTACT LENS; CORNEA DISEASE; CORNEA LIMBUS; CYTOLOGY; DEMOGRAPHY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; LIMBAL STEM CELL DEFICIENCY; LIMBAL STEM CELL TRANSPLANTATION; MALE; MELANOSIS; MULTIPLE CYCLE TREATMENT; OBSERVATIONAL STUDY; ONCOLOGY; OPHTHALMOLOGY; PATIENT SAFETY; PRIMARY ACQUIRED MELANOSIS WITH ATYPIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CELL COUNT; CONJUNCTIVAL DISEASES; CORNEAL DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIMBUS CORNEAE; MALE; MELANOSIS; MIDDLE AGED; MITOMYCIN; RETROSPECTIVE STUDIES; RISK FACTORS; STEM CELLS; VISUAL ACUITY;

EID: 77049094647     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.07.032     Document Type: Article

References (25)

1. Folberg R., and McLean I.W. Primary acquired melanosis and melanoma of the conjunctiva: terminology, classification, and biologic behavior. Hum Pathol 17 (1986) 652-654
2. Jakobiec F.A., Rini F.J., Fraunfelder F.T., and Brownstein S. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma: experience with 62 cases. Ophthalmology 95 (1988) 1058-1070
3. Codere F., Brownstein S., Garwood J.L., and Dresner S.C. Carbon dioxide laser treatment of the conjunctiva and the cornea. Ophthalmology 95 (1988) 37-45
4. Liesegang T.J. Pigmented conjunctival and scleral lesions. Mayo Clin Proc 69 (1994) 151-161
5. Finger P.T., Milner M.S., and McCormick S.A. Topical chemotherapy for conjunctival melanoma. Br J Ophthalmol 77 (1993) 751-753
6. Yeatts R.P., Ford J.G., Stanton C.A., and Reed J.W. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. Ophthalmology 102 (1995) 1338-1344
7. Finger P.T., Czechonska G., and Liarikos S. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol 82 (1998) 476-479
8. Frucht-Pery J., Sugar J., Baum J., et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology 104 (1997) 2085-2093
9. Daniell M., Maini R., and Tole D. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia. Clin Experiment Ophthalmol 30 (2002) 94-98
10. Heigle T.J., Stulting R.D., and Palay D.A. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol 124 (1997) 397-399
11. Wilson M.W., Hungerford J.L., George S.M., and Madreperla S.A. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 124 (1997) 303-311
12. Frucht-Pery J., and Pe'er J. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia. Arch Ophthalmol 114 (1996) 1261-1264
13. Demirci H., McCormick S.A., and Finger P.T. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Arch Ophthalmol 118 (2000) 885-891
14. Pe'er J., and Frucht-Pery J. The treatment of primary acquired melanosis (PAM) with atypia by topical mitomycin C. Am J Ophthalmol 139 (2005) 229-234
15. Frucht-Pery J., and Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 117 (1994) 164-168
16. Shields C.L., Naseripour M., Shields J.A., and Eagle Jr. R.C. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma. Ophthalmology 109 (2002) 2129-2133
17. Shields C.L., Naseripour M., and Shields J.A. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 133 (2002) 601-606
18. Khong J.J., and Muecke J. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol 90 (2006) 819-822
19. Dudney B.W., and Malecha M.A. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. Am J Ophthalmol 137 (2004) 950-951
20. Prabhasawat P., and Tseng S.C. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch Ophthalmol 115 (1997) 1360-1367
21. Tseng S.C. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 92 (1985) 728-733
22. Puangsricharern V., and Tseng S.C. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology 102 (1995) 1476-1485
23. Billing K., Karagiannis A., and Selva D. Punctal-canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia. Am J Ophthalmol 136 (2003) 746-747
24. Kopp E.D., and Seregard S. Epiphora as a side effect of topical mitomycin C. Br J Ophthalmol 88 (2004) 1422-1424
25. Sacu S., Segur-Eltz N., Horvat R., et al. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. Am J Ophthalmol 136 (2003) 375-377